Ohio Public Employees Retirement System (OPERS)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Sell
321,841
-434,668
-57% -$18.7M 0.05% 347
2026
Q1
$27.8M Buy
+756,509
New +$35.8M 0.09% 202

Other funds holding NVO

Ohio Public Employees Retirement System (OPERS)'s NVO Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Novo Nordisk (NVO) stake by 57% in Q2 2026, selling an estimated $18.7M and leaving 321,841 shares worth $15.4M. The position accounts for 0.05% of the portfolio, ranked #347.

Ohio Public Employees Retirement System (OPERS) first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. The position peaked at $27.8M in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 321,841 shares of Novo Nordisk worth $15.4M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 434,668 Novo Nordisk shares in Q2 2026, an estimated $18.7M.
  • Novo Nordisk made up 0.05% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #347 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Novo Nordisk position peaked at $27.8M in Q1 2026.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.